Lexicon Pharmaceuticals: Upgrading On Sotagliflozin HCM Data In Q1 '27 And More

🇺🇸 Seeking Alpha (US) —
Lexicon Pharmaceuticals: Upgrading On Sotagliflozin HCM Data In Q1 '27 And More

AI Summary

Lexicon Pharmaceuticals is being upgraded based in part on anticipated Q1 2027 data for sotagliflozin in hypertrophic cardiomyopathy. The article title also indicates discussion of additional factors, but provides no further details.

Markets Health Lexicon Pharmaceuticals sotagliflozin hypertrophic cardiomyopathy clinical data analyst upgrade

Read original source →